...
首页> 外文期刊>Biomaterials >pH-sensitive polymer-liposome-based antigen delivery systems potentiated with interferon-gamma gene lipoplex for efficient cancer immunotherapy
【24h】

pH-sensitive polymer-liposome-based antigen delivery systems potentiated with interferon-gamma gene lipoplex for efficient cancer immunotherapy

机译:pH敏感的基于聚合物脂质体的抗原递送系统,可通过干扰素-γ基因脂质复合物增强,可用于有效的癌症免疫治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Potentiation of pH-sensitive liposome-based antigen carriers with IFN-gamma gene lipoplexes was attempted to achieve efficient induction of tumor-specific immunity. 3-Methylglutarylated poly(glycidol) (MGluPG)-modified liposomes and cationic liposomes were used, respectively, for the delivery of antigenic protein ovalbumin (OVA) and IFN-gamma-encoding plasmid DNA (pDNA). The MGluPG-modified liposomes and the cationic liposome-pDNA complexes (lipoplexes) formed hybrid complexes via electrostatic interactions after their mixing in aqueous solutions. The hybrid complexes co-delivered OVA and IFN-gamma-encoding pDNA into DC2.4 cells, a murine dendritic cell line, as was the case of MGluPG-modified liposomes for OVA or the lipoplexes for pDNA. Both the lipoplexes and the hybrid complexes transfected DC2A cells and induced IFN-gamma protein production, but transfection activities of the hybrid complexes were lower than those of the parent lipoplexes. Subcutaneous administration of hybrid complexes to mice bearing E.G7-OVA tumor reduced tumor volumes, which might result from the induction of OVA-specific cytotoxic T lymphocytes (CTLs). However, the hybrid complex-induced antitumor effect was the same level of the MGluPG-modified liposome-mediated antitumor immunity. In contrast, an extremely strong antitumor immune response was derived when these liposomes and lipoplexes without complexation were injected subcutaneously at the same site of tumor-bearing mice. Immunohistochemical analysis of tumor sections revealed that immunization through the liposome-lipoplex combination promoted the infiltration of CTLs to tumors at an early stage of treatment compared with liposomes, resulting in strong therapeutic effects. (C) 2015 Elsevier Ltd. All rights reserved.
机译:尝试用IFN-γ基因脂质复合物增强pH敏感的基于脂质体的抗原载体,以实现肿瘤特异性免疫的有效诱导。使用3-甲基戊二酰化聚缩水甘油(MGluPG)修饰的脂质体和阳离子脂质体分别递送抗原蛋白卵清蛋白(OVA)和IFN-γ编码质粒DNA(pDNA)。 MGluPG修饰的脂质体和阳离子脂质体-pDNA复合物(脂质复合物)在水溶液中混合后通过静电相互作用形成杂合复合物。杂合复合物将OVA和编码IFN-γ的pDNA共递送到DC2.4细胞(鼠类树突状细胞系)中,就像MGluPG修饰的OVA脂质体或pDNA脂质复合物一样。脂质复合物和杂合复合物都转染DC2A细胞并诱导IFN-γ蛋白产生,但是杂合复合物的转染活性低于亲本脂质复合物。对携带E.G7-OVA肿瘤的小鼠皮下施用杂合复合物可减少肿瘤体积,这可能是由诱导OVA特异性细胞毒性T淋巴细胞(CTL)引起的。但是,杂合复合物诱导的抗肿瘤作用与MGluPG修饰的脂质体介导的抗肿瘤免疫力相同。相反,当将这些没有复合的脂质体和脂质复合物皮下注射到荷瘤小鼠的相同部位时,会产生极强的抗肿瘤免疫反应。肿瘤切片的免疫组织化学分析显示,与脂质体相比,通过脂质体-脂质复合物组合进行的免疫在治疗的早期促进了CTL向肿瘤的浸润,从而产生了强大的治疗效果。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号